2024 New Research on Medical Device Industry:
- Vietnam Medical Devices Industry Research Report 2024-2033
- Singapore Medical Devices Industry Research Report 2024-2033
- Indonesia Medical Devices Industry Research Report 2024-2033
This list contains the top 10 medical device companies in China ranked by their sales revenue based on public data sources.
Top 10 medical device companies
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is the largest medical device enterprise in China. In 2018, the company’s operating revenue reached CNY 13,753 million, increasing by 23.09% YOY; net profits reached CNY 3,719 million, increasing by 43.65% YOY. The company’s products cover life information and support, in-vitro diagnostics, and medical imaging.
The surge in profitability was attributable to the improvement of management efficiency and the investment in R&D of high-end medical devices. (In 2018, investment in R&D accounted for 10.33% of the company’s operating revenue.)
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
In 2018, the operating revenue of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. reached CNY 4,183 million, increasing by 18.12% YOY; the net profits attributable to listed-company shareholders amounted to CNY 727 million, increasing by 22.82% YOY.
The company specializes in providing home medical equipment, medical clinical products and related medical services. It provides products that cover fields such as oxygen respirators, blood pressure and blood sugar, rehabilitation nursing, medical first aid, surgical instruments, equipment used in traditional Chinese medicine, medicinal plasters and polymer sanitary dressings as well as hospital disinfection solutions.
Lepu Medical Technology (Beijing) Co., Ltd.
In 2018, the operating revenue of Lepu Medical Technology (Beijing) Co., Ltd. reached CNY 6,356 million, increasing by 40.08% YOY; net profits reached CNY 1,219 million, increasing by 35.55% YOY. The company specializes in medical devices, medicine, medical services and new forms of medical business.
Its annual report shows that the revenue from medical devices (including production and distribution of medical devices) takes up the largest proportion of its operating revenue. In 2018, the company’s revenue from medical devices reached CNY 2,907 million, increasing by 15.31% YOY; net profits from medical devices reached CNY 769 million, increasing by 19.34% YOY.
Related reports:Patient Monitoring Devices Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030Ventilators Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030
Neusoft Corporation
Established in 1991, Neusoft Corporation is the first software enterprise listed in China and the first to provide information services for China’s medical industry. According to its annual report, in 2018, its operating revenue reached CNY 7,171 million, increasing by 0.55% YOY; net profits attributable to listed company shareholders reached CNY 110 million, decreasing by 89.60% YOY.
In terms of medical business service data, Neusoft Corporation provides software and services to nearly 500 Grade III hospitals, over 2,500 medical institutions, over 30,000 community-level medical institutions and clinics and 190,000 designated medical institutions and retail pharmacies.
Shinva Medical Instrument Co., Ltd.
According to its annual report, in 2018, the operating revenue of Shinva Medical Instrument Co., Ltd. reached CNY 10,284 million, increasing by 3.01% YOY; net profits attributable to listed company shareholders reached CNY 23 million, decreasing by 65.23% YOY.
The annual report shows that the company specializes in medical devices, pharmaceutical equipment, medical services and medical trade. In 2018, the company’s operating revenue from medical devices reached CNY 2,253 million, increasing by 9.34% YOY.
Dian Diagnostics Group Co., Ltd.
In 2018, the operating revenue of Dian Diagnostics Group Co., Ltd. totaled CNY 6.97 billion, increasing by 39.20% YOY. The growth rate has stayed above 29% for 10 consecutive years, The company’s net profits amounted to CNY 390 million, increasing by 11.20% YOY.
The company specializes in diagnostic products, diagnostic services, health check-ups, cold chain
logistics, forensic assessment and financial leasing. In 2018, the operating revenue from diagnostic products was the highest, reaching about CNY 4.40 billion with a YOY increase of 49.22%; the operating revenue from forensic assessment grew fastest, reaching about CNY 62,313,900 with a YOY increase of 128.68%.
Autobio Diagnostics Co., Ltd.
Established in 1999, Autobio Diagnostics Co., Ltd. specialized in the R&D, production, sale and services of in-vitro diagnostic reagents and instruments that cover immunology, biochemistry, microbiology and other testing fields. In 2018, the company’s operating revenue reached CNY 1.93 billion, increasing by 37.82% YOY; net profits attributable to parent company shareholders reached CNY 563 million, increasing by 25.98% YOY.
Bluesail Medical Co., Ltd.
According to its annual report, in 2018, the operating revenue of Bluesail Medical Co., Ltd. reached CNY 2,653 million, increasing by 68.35% YOY; net profits attributable to listed company shareholders reached CNY 347 million, increasing by 72.61% YOY.
The company mainly produces disposable medical gloves and household gloves for medical examination and protection, food processing and electronics companies. Its operating revenue from health protective gloves was about CNY 1.60 billion, increasing by 5.15% YOY; operating profits totaled about CNY 1.20 billion, increasing by about 17.57% YOY; gross profit margin reached 23.91%, decreasing by 8.04% YOY.
Jafron Biomedical Co., Ltd.
In 2018, the operating revenue of Jafron Biomedical Co., Ltd. reached CNY 1,017 million, increasing by about 41.48% YOY; net profits attributable to listed company shareholders reached CNY 402 million, increasing by 41.34% YOY; investment in R&D amounted to about CNY 46.13 million, increasing by 73.25% YOY and accounting for 4.54% of the company’s operating revenue.
Hefei Meyer Optoelectronic Technology Inc.
In 2018, the operating revenue of Hefei Meyer Optoelectronic Technology Inc. reached CNY 1.24 billion, increasing by 13.33% YOY; net profits attributable to listed company shareholders reached CNY448 million, increasing by 22.82% YOY.